Predictors and patterns of red blood cell transfusion use among newly diagnosed cancer patients with chemotherapy-associated anemia in Western Denmark (1998-2003)

Clinical Epidemiology

Volumn 3, Issue 1, 2011, Pages 91-99

  Yong, Mellissa ^a   Riis, Anders H ^b   Fryzek, Jon P ^b   Møller, Bjarne K ^c   Johnsen, Søren P ^b  

^a AMGEN INC   (United States)

^b Department of Epidemiology and Computational Biology ^*  (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anemia; Epidemiology; Red blood cell transfusions

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DIGESTIVE SYSTEM CANCER; ERYTHROCYTE TRANSFUSION; FEMALE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HEALTH CARE UTILIZATION; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PREDICTION; PRESCHOOL CHILD; PROSTATE CANCER; RISK FACTOR; SOLID TUMOR; THERAPY EFFECT; URINARY TRACT CANCER;

EID: 79952973620     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/CLEP.S17146     Document Type: Article

References (24)

1. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999;91:1616-1634.
2. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91:2214-2221.
3. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40:2293-2306.
4. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083-4107.
5. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood. 2002;100:2303-2320.
6. Engert E. Recombinant human erythropoietin as an alternative to blood transfusion in cancer-related anemia. Dis Manage Health Outcomes. 2000;8:259-272.
7. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts-blood transfusion. N Engl J Med. 1999; 340:438-447.
8. Williamson LM, Lowe S, Love EM, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999; 319:16-19.
9. Schrijvers D, De Samblanx H, Roila F. Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for use. Ann Oncol. 2010;21 Suppl 5: v244-v247.
10. Aapro MS, Link H. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist. 2008;13 Suppl 3:33-36.
11. Rizzo JD, Brouwers M, Hurley P, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010;28:4996-5010.
12. Rizzo JD, Brouwers M, Hurley P, et al. American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010;116:4045-4059.
13. National Comprehensive Cancer Network (NCCN). Cancer- and Chemotherapy- induced Anemia, Version 2.2011. 2011. http://www.nccn.org/professionals/physician_gls/PDF/anemia.pdf. Accessed November 3, 2010.
14. Van der Poel C, Janssen M. The collection, testing, and use of blood and blood products in Europe in 2003. http://www.coe.int/t/dg3/health/Source/2003reportfinal_en.pdf. Accessed August 26, 2010.
15. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
16. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull. 1997;44: 535-539.
17. Danish Medicines Agency. Redegørelse for blodproduktområdet 2007. Copenhagen; 2008.
18. Cummings P. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes". Am J Epidemiol. 2004;159:213; author reply 214-215.
19. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702-706.
20. Michon J. Incidence of anemia in pediatric cancer patients in Europe: results of a large, international survey. Med Pediatr Oncol. 2002; 39:448-450.
21. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol. 1993;16:22-25.
22. Heddens D, Alberts D, Garcia D, et al. Factors associated with platinum-induced anemia in ovarian cancer (ovca) patients (pts) in Southwest Oncology Group(s) studies [abstract 1387]. Proc ASCO. 1998;17:359a.
23. Dalton J, Bailey N, Barrett-Lee P, O'Brien M. Multicenter UK audit of anemia in patients receiving cytotoxic chemotherapy. Paper presented at: American Society of Clinical Oncology; 1998.
24. World Health Organization (WHO). Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death: Seventh Revision. Geneva: WHO; 1957.